{"id":108516,"date":"2021-03-03T14:02:38","date_gmt":"2021-03-03T14:02:38","guid":{"rendered":"https:\/\/fin2me.com\/?p=108516"},"modified":"2021-03-03T14:02:38","modified_gmt":"2021-03-03T14:02:38","slug":"economist-bidens-1-9-trillion-stimulus-plan-is-not-too-large","status":"publish","type":"post","link":"https:\/\/fin2me.com\/markets\/economist-bidens-1-9-trillion-stimulus-plan-is-not-too-large\/","title":{"rendered":"Economist: Biden's $1.9 trillion stimulus plan is not too large"},"content":{"rendered":"

A version of this story first appeared in CNN Business’ Before the Bell newsletter. Not a subscriber? You can sign up <\/em>right here<\/em>.<\/em><\/p>\n

London (CNN Business)<\/cite>Those betting on an economic boom in the United States this spring and summer just got a dose of very good news.<\/p>\n

What’s happening: President Joe Biden has announced that the United States will have enough vaccine supply for every adult by the end of May after Merck agreed to help manufacture a recently authorized vaccine developed by Johnson & Johnson.
\nThat dramatically accelerates the country’s inoculation timeline. The Biden administration previously aimed to procure enough shots for all American adults by the end of July.<\/p>\n